ES2145132T3 - Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos. - Google Patents

Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.

Info

Publication number
ES2145132T3
ES2145132T3 ES94909807T ES94909807T ES2145132T3 ES 2145132 T3 ES2145132 T3 ES 2145132T3 ES 94909807 T ES94909807 T ES 94909807T ES 94909807 T ES94909807 T ES 94909807T ES 2145132 T3 ES2145132 T3 ES 2145132T3
Authority
ES
Spain
Prior art keywords
pct
active ingredients
stable
storage
supply system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94909807T
Other languages
English (en)
Inventor
Michael W Fountain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fountain Pharmaceuticals Inc
Original Assignee
Fountain Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fountain Pharmaceuticals Inc filed Critical Fountain Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2145132T3 publication Critical patent/ES2145132T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN SISTEMA DE DISTRIBUCION DE VACUNAS QUE UTILIZA SDMC''S PARA DISTRIBUIR ANTIGENOS A LUGARES MUCOSOS PARA ESTIMULAR LA PRODUCCION DE INMUNOGLOBULINA. LAS VACUNAS COMPRENDEN SUBUNIDADES DE PATOGENO INCORPORADAS DENTRO DE LOS SDMC''S. SE DESCRIBE TAMBIEN UN METODO PARA LA PREPARACION DE UNA SOLUCION PRECURSORA ANTOESTABLE USADA PARA PREPARAR EL SISTEMA DE DISTRIBUCION DE VACUNAS Y `UTIL PARA ENCAPSULACION REMOTA DE INGREDIENTES ACTIVOS.
ES94909807T 1993-02-26 1994-02-25 Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos. Expired - Lifetime ES2145132T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2397193A 1993-02-26 1993-02-26

Publications (1)

Publication Number Publication Date
ES2145132T3 true ES2145132T3 (es) 2000-07-01

Family

ID=21818176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94909807T Expired - Lifetime ES2145132T3 (es) 1993-02-26 1994-02-25 Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.

Country Status (13)

Country Link
US (1) US5879703A (es)
EP (1) EP0688206B1 (es)
JP (1) JPH08507077A (es)
AT (1) ATE192331T1 (es)
AU (1) AU677826B2 (es)
CA (1) CA2157125A1 (es)
DE (1) DE69424279T2 (es)
DK (1) DK0688206T3 (es)
ES (1) ES2145132T3 (es)
HK (1) HK1012991A1 (es)
PT (1) PT688206E (es)
SG (1) SG44911A1 (es)
WO (1) WO1994018950A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
EP1754488A1 (en) 1999-05-24 2007-02-21 Introgen Therapeutics, Inc. Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
US10293056B1 (en) 2000-05-24 2019-05-21 Board Of Regents, The University Of Texas System Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
EP3219307B1 (en) 2005-12-30 2021-09-08 NuVessl Inc. Nanolipidic particles
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
WO2007092944A2 (en) * 2006-02-08 2007-08-16 Introgen Therapeutics, Inc. Compositions and methods involving gene therapy and proteasome modulation
US20140335166A1 (en) * 2013-05-08 2014-11-13 Michael W. Fountain Methods of Making and Using Nano Scale Particles
DK2245464T3 (en) 2008-01-25 2017-02-20 Multivir Inc P53 BIOMARKETS
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
CA2767392C (en) 2009-07-06 2017-03-14 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2840079C (en) 2010-07-06 2018-07-03 Variation Biotechnologies Inc. Compositions and methods for treating influenza
WO2012097346A1 (en) 2011-01-13 2012-07-19 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
AU2012205315B2 (en) * 2011-01-13 2017-05-04 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
US9333675B2 (en) * 2012-01-10 2016-05-10 Hzo, Inc. Profiles for precursors to polymeric materials
EP2802353A4 (en) 2012-01-12 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
US20150079077A1 (en) 2012-01-27 2015-03-19 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
EP3283045B1 (en) * 2015-04-13 2021-02-17 Fountain Technologies International, LLC One-step method for production of ultra-small lipid structures
US20200078316A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
US11458092B2 (en) 2018-12-14 2022-10-04 NuVessl, Inc. Composition with enhanced passenger molecule loading

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1695599A (en) * 1927-05-24 1928-12-18 Edward L Merzoian Dispenser
US2261877A (en) * 1940-05-15 1941-11-04 John G Erickson Dispensing device
US2712400A (en) * 1952-04-28 1955-07-05 Wayne C Stauffer Dispensing means for paste tubes
US3780911A (en) * 1972-01-03 1973-12-25 D Paige Dispensing apparatus for collapsible tube container
AU549154B2 (en) * 1982-12-07 1986-01-16 Motion, J.A.C. Collapsible tube expressor
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4755375A (en) * 1984-01-27 1988-07-05 Associated Universities, Inc. Method and kit for the selective labeling of red blood cells in whole blood with TC-99M
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
EP0231039B1 (en) * 1986-01-14 1992-01-08 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Process for preparing immunological complexes and pharmaceutical composition containing these complexes
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
IL90561A (en) * 1988-06-08 1993-08-18 Fountain Pharm Inc Method for making solvent dilution microcarriers
US5133965A (en) * 1988-06-08 1992-07-28 Fountain Pharmaceuticals, Inc. Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren

Also Published As

Publication number Publication date
DK0688206T3 (da) 2000-09-25
US5879703A (en) 1999-03-09
AU6250694A (en) 1994-09-14
CA2157125A1 (en) 1994-09-01
EP0688206A1 (en) 1995-12-27
JPH08507077A (ja) 1996-07-30
AU677826B2 (en) 1997-05-08
EP0688206B1 (en) 2000-05-03
DE69424279T2 (de) 2000-12-21
DE69424279D1 (de) 2000-06-08
ATE192331T1 (de) 2000-05-15
PT688206E (pt) 2000-08-31
HK1012991A1 (en) 1999-08-13
WO1994018950A1 (en) 1994-09-01
SG44911A1 (en) 1997-12-19

Similar Documents

Publication Publication Date Title
ES2145132T3 (es) Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.
FI870155A0 (fi) Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
Auclair et al. POTENT INHIBITORY ACTIVITY OF [D-LEU6, DES-GLY-NH21Q] LHRH ETHYLAMIDE ON LH/hCG AND PRL TESTICULAR RECEPTOR LEVELS IN THE RAT
BADGER et al. The luteinizing hormone-releasing hormone (LHRH) desensitized rat pituitary: luteinizing hormone responsiveness to LHRH in vitro
BR9408377A (pt) Composto composição farmacêutica processo para estimular a liberação de hormônio de crescimento da pituitária e uso do composto
NO20014859L (no) Raskt dispergerbare doseringsformer inneholdende fiskegelatin
YU47899B (sh) Postupak za dobivanje preparata koji sprečava prenošenje polnih bolesti i tampona koji ga sadrži
NZ217821A (en) Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
DE69519685T2 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
Santen et al. Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma
ATE388687T1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
PT97476A (pt) Processo de preparacao de composicoes farmaceuticas para distribuicao sub-lingual de medicamentos a base de, entre outros, calcitonina, hormona de crescimento humano ou nifedipina
HU901085D0 (en) Process for producing substituted benzimidazole and pharmaceutical preparatives containing it
HU9303230D0 (en) Use of lanoline derivatives for promotion of transdermal resorption of drugs and other biological substances
DE68905613D1 (de) Pharmazeutische zubereitung.
GB9906695D0 (en) Vaccine composition
Zorn et al. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
AU8316291A (en) Galenical preparation method for preparing a therapeutical composition particularly based on aspirin
EP0282501A1 (en) Regulating animal reproduction
WO1995032286A3 (en) Immunogenic carcinoembryonic antigen and methods of use and production
REICHLIN et al. Thyroid inhibition in the rat: comparison of effects of thyroid hormone treatment, hypophysectomy and anti-TSH antibody
IT1226728B (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
AU4954993A (en) Ready-to-inject azosemide solutions
Stewart Hypersensitivity reexamined

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 688206

Country of ref document: ES